Search
Menu
Meadowlark Optics - SEE WHAT

MIP Technologies AB

Facebook X LinkedIn Email
MIP Technologies AB of Lund, Sweden, has entered into a collaboration with sanofi-aventis of Paris to develop molecularly imprinted polymers that will be used to analyze pharmacologically active peptides from plasma samples. The French company will have exclusive rights to use the polymer for analyzing proprietary peptides, while the Swedish company will retain the rights for its use in other applications.
Lumencor Inc. - ZIVA Light Engine 3-24 MR

Published: February 2009
BiophotonicsMIP Technologies ABmolecularly imprinted polymersNews & Features

We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.